Ouvrez la porte J, Génamique, Google Scholar, ISA (résumés scientifiques indiens), Base de données CAS (Chemical Abstract Services), CABI (Royaume-Uni), Index Copernic, Hinar, EBSCO, Répertoire des périodiques d'Ulrich, Pesticides botaniques , Résumés de mauvaises herbes, AgBiotechNet, Ressource VetMed, Résumés de physiologie des cultures, Abrégés d'agroforesterie, Résumés helminthologiques, Horticulture ornementale, Abrégés de phytogénétiques, Novelles and informations on the porc, Abrégés sur les sciences laitières, Basis der Données sur Landwirtschaftliche Wirtschaft, Basis für Parasitologie-Studien, CAB-Lebensläufe, Zoologisches Register, Neue und nachträgliche Informationen, Basis für Ernährungs- und Lebensmittelwissenschaften, Basis für biologische Forschung, Weltgesundheit, ABC Chimie, Zentrum des Wissenschaften,SCIMAGO ist ein Zug,der viele andere Charaktere verrät.
Mannuru M
Background: The NHPM is a central initiative targeting approximately 50 Cr deprived population of the country. When beneficiaries seek service from the provider..Voir plus»
Chantal Hartmans, Stefanie Heremans, Marieke Lagrain, Kristin Van Asch and Birgitte Schoenmakers
Objective: To investigate the influence of the GP’s attire on the confidence that patients have in their GP as a medical expert and on the patient’s comfort level (d..Voir plus»
Renato Nishioka
| Voir plus»
Rapport de cas
Androgen Targeted Therapy in Salivary Duct Carcinoma of Submandibular Gland-A Case ReportGeorge P Voir plus»
Rapport de cas
Demyelinating Lesion Isolated to the Lateral Geniculate NucleusJoanna Suski and Myla Goldman Symptomatic retrochiasmatic lesions due to demyelinating disease are rare in multiple sclerosis. The most
Série de cas
177Lu-PSMA Therapy an Alternative Therapy for Metastatic Castrate Resistant Prostate Cancer with Suboptimal Response: Are we ready for itSharifa Al Sheebani, Ajda Altinoz*, Lutfi A Kurban, Saadia Ibrahim, Gehad Nassar, Hussam Sadaqa, Jawaher A Ansari, Sulaman R Magdub, Sahar Mohsin, Iram Syed, Aftab Bhatti and Rizwan Syed Introduction: Lutetium-177-PSMA-617 (177Lu-PSMA) is used as the last treatment option in metastatic castrate resistant prostate cancer (mCRPC). We p..Voir plus» |